Somatic cell cloned transgenic bovine neurons for transplantation in parkinsonian rats

Nature Medicine

Volumn 4, Issue 5, 1998, Pages 569-574

  Zawada, W Michael ^a   Cibelli, Jose B ^b,c   Choi, Paul K ^a   Clarkson, Edward D ^a   Golueke, Paul J ^b   Witta, Samir E ^a   Bell, K Pat ^a   Kane, Jeff ^b   De Leon, F Abel Ponce ^c   Jerry, D Joseph ^c   Robl, James M ^c   Freed, Curt R ^a   Stice, Steven L ^b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b Advanced Cell Technology   (United States)

^c UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATTLE; CELL CLONING; CELL NUCLEUS; CELL TRANSFER; CELL TRANSPLANTATION; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; EMBRYO; FETUS; IMMUNE DEFICIENCY; MALE; MESENCEPHALON; MOTOR PERFORMANCE; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL; PUTAMEN; RAT; SOMATIC CELL; TRANSGENIC ANIMAL;

ANIMALIA; BOS TAURUS; BOVINAE; PARKINSONIA;

EID: 17344392886     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0598-569     Document Type: Article

References (38)

1. Freed, C.R. et al., Transplantation of human fetal dopamine cells for Parkinson's disease. Arch. Neurol. 47, 505-512 (1990).
2. Lindvall, O. et al. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science 247, 574-577 (1990).
3. Freed, C.R. et al. Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease. N. Engl. J. Med. 327, 1549-1555 (1992).
4. Peschanski, M. et al. Bilateral motor improvement and alteration of L-dopa effect in two patients with Parkinson's disease following intrastriatal transplantation of foetal ventral mesencephalon. Brain 117, 487-499 (1994).
5. Kordower, J.H. et al. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N. Engl. J. Med. 332, 1118-1124 (1995).
6. Freeman, T.B. et al. Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease. Ann. Neurol. 38, 379-388 (1995).
7. Kopyov, O.V. et al. Clinical study of fetal mesencephalic intracerebral transplants for the treatment of Parkinson's disease. Cell Transplantation 5, 327-337 (1996).
8. Wenning, G.K. et al. Short-and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease. Ann. Neurol. 42, 95-107 (1997).
9. Freeman, T.B. et al. Cross-species intracerebral grafting of embryonic swine dopaminergic neurons. in Progress in Brain Research (Eds. Gash D.M. & Sladek J. R.) 473-477 (Elsevier, NY, 1988).
10. Huffaker, T.K. et al. Xenografting of fetal pig ventral mesencephalon corrects motor asymmetry in the rat model of Parkinson's disease. Exp. Brain Res. 77, 329-336 (1989).
11. Björklund, A., Stenevi, U., Dunnett, S.B. & Gage, F.H. Cross-species neural grafting in a rat model of Parkinson's disease. Nature 298, 652-654 (1982).
12. Galpern, W.R., Burns, L.H., Deacon, T.W., Dinsmore, J. & Isacson, O. Xenotransplantation of porcine fetal ventral mesencephalon in a rat model of Parkinson's disease: Functional recovery and graft morphology. Exp. Neurol. 140, 1-13 (1996).
13. Deacon, T. et al. Histological evidence of fetal pig neural cell survival after transplantation into a patient with Parkinson's disease. Nature Med. 3, 350-353 (1997).
14. Wilmut, I., Schnieke, A.E., McWhir, J., Kind, A.J. & Campbell, K.H.S. Viable offspring derived from fetal and adult mammalian cells. Nature 385, 810-813 (1997).
15. Schnieke, A.E., et al. Human factor IX transgenic sheep produced by transfer of nuclei from transfected fetal fibroblasts. Science 278, 2130-2133 (1997).
16. Chervonsky, A.W., et al. The role of Fas in autoimmune diabetes. Cell 89, 17-24 (1997).
17. Takayama H. et al. Basic fibroblast growth factor increases dopaminergic graft survival and function in a rat model of Parkinson's disease. Nature Med. 1, 53-58 (1995).
18. Clarkson, E.D., Zawada, W.M. & Freed, C.R. GDNF improves survival and reduces apoptotic cell death in human embryonic dopaminergic neurons in vitro. Cell Tissue Res. 289, 207-210 (1997).
19. +-damaged dopaminergic fibers by treatment of mesencephalic cultures with EGF and basic FGF. Brain Res. 559, 83-97 (1992).
20. Beck, K.D., Knüsel, B. & Hefti, F. The nature of the trophic action of brain-derived neurotrophic factor, des (1-3)-insulin-like growth factor-1 and basic fibroblast growth factor on mesencephalic dopaminergic neurons developing in culture. Neuroscience 52, 855-866 (1993).
21. Fawcett, W., Barker, R.A. & Dunnett, S.B. Dopaminergic neuronal survival and the effects of bFGF in explant, three dimensional and monolayer cultures of embryonic rat ventral mesencephalon. Exp. Brain Res. 106, 275-282 (1995).
22. Zawada, W.M., Kirschman, D.L., Cohen, J.J., Heidenreich, K.A. & Freed, C.R. Growth factors rescue embryonic dopamine neurons from programmed cell death. Exp. Neurol. 140, 60-67 (1996).
23. Hyman, C. et al. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 350, 230-232 (1991).
24. Dole, R. F., Crandall, J.E., Dyer, C.A., Aucoin, J.M. & Smith, F.I. Comparison of promoter strengths on gene delivery into the mammalian brain cells using AAV vectors. Gene Therapy 3, 437-447 (1996).
25. Prather, R.S., Sims, M.N. & First, N.L. Nuclear transplantation in early pig embryos. Biol. Reprod. 41, 414-418 (1989).
26. Pursel, V.G. & Rexroad, C.E. Jr. Status of research with transgenic farm animals. J. Animal Sci. 71 (Suppl. 3), 10-19 (1993).
27. Brundin, P. et al. Behavioral effects of human fetal dopamine neurons grafted in a rat model of Parkinson's disease. Exp. Brain Res. 65, 235-240 (1986).
28. Saadi, S. & Platt, L.J. Immunology of xenotransplantation. Life Sci. 62, 365-387 (1998).
29. Sandberg, P.R., Borlongan, C.V., Saporta, S. & Cameron, D.F. Testis-derived sertoli cells survive and provide localized immunoprotection for xenografts in rat brain. Nature Biotech. 14, 1692-1695 (1996).
30. Frederickson, R.M., Micheau, M.R., Iwamoto, A. & Miyamoto, N. G. 5′ flanking and first intron sequences of the human β-actin gene required for efficient promoter activity. Nucleic Acid Res. 17, 253-270 (1989).
31. Aki, T., Yanagisawa, S. & Akanuma, H. Identification and characterization of positive regulatory elements in the human glyceraldehyde 3-phosphate dehydrogenase gene promoter. J. Biochem. 122, 271-278 (1997).
32. Wagener, S., Norley, S., zur Megede J., Kurth, R. & Cichutek, K. Induction of antibodies against SIV antigens after intramuscular nucleic acid inoculation using complex expression constructs. J. Biotech. 44, 59-65 (1996).
33. Peel, A.L., Zolotukhin S., Schrimsher, C.W., Muzyczka, N. & Reier, P.J. Efficient transduction of green fluorescent protein in spinal cord neurons using adeno-associated virus vectors containing cell type-specific promoters. Gene Therapy 4, 16-24 (1997).
34. Stice, S.L., Strelchenko, N.S., Keefer, C.L. & Matthews, L. Pluripotent bovine embryonic cell lines direct embryonic development following nuclear transfer. Biol. Reprod. 54, 100-110 (1996).
35. Dunnett, S.B. & Björklund, A. Staging and dissection of rat embryos. in Neural Transplantation: A Practical Approach (Dunnett, S.B. & Björklund, A.) 1-19 (Oxford University Press, NY, 1992).
36. Richards, J.B., Sabol, K.E., & Freed, C.R. Unilateral dopamine depletion causes bilateral deficits in conditioned rotation in rats. Pharmacol. Biochem. Behav. 36, 217-223 (1990).
37. Abercrombie, M. Estimation of nuclear population from microtome sections. Anat. Rec. 94, 239-247 (1946).
38. Shedlock, A.M., Haygood, M.G., Pietsch, T.W. & Bentzen, P. Enhanced DNA extraction and PCR amplification of mitochondrial genes from formalin-fixed museum specimens. BioTech. 22, 394-399 (1997).